Current Investments

Our investment portfolio includes these selected examples. Original underwriting dates shown, with dollar amounts rounded to nearest million.

Current Investments

Acer Therapeutics

 03.07.22
$13.5 million
Structured Credit

Advanced Oxygen Therapy

03.21.22
$12.0 million
Structured Credit

Best ABT

11.12.18
$5.8 million
Royalty Reorganization

BIOLASE

11.09.18
$15.0 million
Structured Credit

Biotricity

12.27.21
$12.0 million
Structured Credit

Cambia

07.31.14
$9.5 million
Royalty Acquisition

Coflex

08.31.20
$4.4 million
Royalty Portfolio Acquisition

Secured Royalty Financing for Pharmaceutical Product

Women’s Health

06.07.13
$3.1 million
Royalty Financing

Elutia

08.10.22
$25.0 million
Structured Credit

Exeevo

07.01.22
$7.5 million
Structured Credit

Epica International

07.25.18
$14.0 million
Structured Credit

Eton Pharmaceuticals

11.14.19
$10.0 million
Structured Credit

Flowonix Medical

12.23.20
$10.0 million
Structured Credit

ForFivo (IntelGenx)

08.05.16
$6.0 million
Royalty Acquisition

4WEB Medical

06.03.19
$20.0 million
Structured Credit

Ideal Implant

04.27.21
$5.0 million
Synthetic Royalty Financing

Iluvien

12.18.20
$16.5 million
Royalty Acquisition

Private Transaction

Immune Globulin Portfolio

12.27.2023
$14.1 million
Royalty Acquisition

Journey Medical Corporation

12.27.2023
$20.0 million
Structured Credit

Kybella

08.31.20
$4.4 million
Royalty Portfolio Acquisition

MedMinder Systems

08.18.22
$25.0 million
Structured Credit

MolecuLight

01.04.22
$10.0 million
Structured Credit

NeoLight

02.17.23
$5.0 million
Structured Credit

Nicoya

10.19.23
$6.0 million
Structured Credit

Secured Royalty Financing for Pharmaceutical Product

Project Duo Royalty

11.30.22
$16.5 million
Royalty Acquisition

Shield Therapeutics

10.19.23
$20.0 million
Structured Credit

Sincerus Pharmaceuticals

03.19.21
$12.3 million
Structured Credit

Sponsor-backed CDMO

 

09.13.23
$5 million
Structured Credit

Trio Healthcare

07.01.21
$9.5 million
Structured Credit

Veru

03.05.18
$12.0 million
Synthetic Royalty Financing